Clinical Trials Directory

Trials / Completed

CompletedNCT02737254

Oxytocin and Attachment-related Interpretation Bias

The Effect of Oxytocin on the Training of Attachment-related Interpretation Bias in Middle Childhood

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
8 Years – 13 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effects of oxytocin and a cognitive bias modification (CBM) procedure on children's trust in their mother.

Detailed description

Previous research has shown that children can be trained to interpret ambiguous interactions with mother in a more secure way by use of a CBM procedure. A secure attachment-related processing bias can causally increase children's trust in mother's availability. The present study tests whether intranasal administration of oxytocin can increase the effect of a secure cognitive bias training. Oxytocin is a neuropeptide that is involved in human attachment and bonding. Intranasal administration of oxytocin can increase trust among people. After oxytocin or placebo administration, children are either trained to interpret ambiguous interactions with mother in a secure way or receive a neutral training unrelated to interpretation of maternal behavior. Pre- and post-intervention children's trust in mother, support seeking behavior and interpretation of maternal behavior is assessed. Moreover, possible oxytocin side-effects will be monitored.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin40 IU/ML nasal spray. One administration: children \<40kg administer 12IU, children \>40kg administer 24IU.
DRUGPlaceboNaCl 0,9 % nasal spray.
OTHERSecure CBM trainingChildren are trained to interpret ambiguous maternal behavior in a secure way.
OTHERNeutral CBM trainingChildren receive a training unrelated to the interpretation of maternal behavior.

Timeline

Start date
2016-03-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-04-13
Last updated
2016-11-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02737254. Inclusion in this directory is not an endorsement.